Insider Selling: Cardiovascular Systems CEO Sells 11,754 Shares of Stock (CSII)
Cardiovascular Systems (NASDAQ:CSII) CEO David Martin unloaded 11,754 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $29.28, for a total transaction of $344,157.12. Following the completion of the transaction, the chief executive officer now directly owns 408,894 shares in the company, valued at approximately $11,972,416. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Cardiovascular Systems (NASDAQ:CSII) traded up 0.17% on Friday, hitting $29.47. 47,828 shares of the company’s stock traded hands. Cardiovascular Systems has a 52-week low of $18.83 and a 52-week high of $37.73. The stock has a 50-day moving average of $28.94 and a 200-day moving average of $30.41. The company’s market cap is $912.4 million.
Cardiovascular Systems (NASDAQ:CSII) last announced its earnings results on Wednesday, August 6th. The company reported ($0.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.28) by $0.03. The company had revenue of $39.56 million for the quarter, compared to the consensus estimate of $37.21 million. The company’s revenue for the quarter was up 37.3% on a year-over-year basis. On average, analysts predict that Cardiovascular Systems will post $-1.11 earnings per share for the current fiscal year.
A number of research firms have recently commented on CSII. Analysts at Benchmark Co. raised their price target on shares of Cardiovascular Systems from $38.00 to $42.00 in a research note on Thursday, August 7th. They now have a “buy” rating on the stock. Analysts at Needham & Company LLC raised their price target on shares of Cardiovascular Systems from $37.00 to $38.00 in a research note on Thursday, August 7th. They now have a “strong-buy” rating on the stock. Four research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Cardiovascular Systems presently has an average rating of “Buy” and a consensus target price of $40.67.
Cardiovascular Systems, Inc (NASDAQ:CSII) is a medical device company.
Receive News & Ratings for Cardiovascular Systems Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.